Risk of Hysterectomy at Time of Myomectomy

NCT07365969 | Completed DMC

• 1 other identifier: FMASU MS 778/2024
• Study Type: observational
• Target: 293
• Locations: 1 country
• Sites: 1

Brief Summary

Uterine fibroids are the commonest tumor affecting the female reproductive tract and many instances they are asymptomatic but in some women there does appear to be an association with heavy menstrual blood loss and possibly subfertility. Classically, treatment has been surgical with hysterectomy the most common approach for women who have completed their fertility and myomectomy for those who wish to conceive. The surgery can be carried out laparoscopically, vaginally and abdominally. The aim of this study is to evaluate the risk of hysterectomy at the time of myomectomy, and the associated 30-day postoperative morbidity.

Conditions

Myomectomy; Fibroid Uterus; Hysterectomy

Keywords

hysterectomy; myomectomy; fibroid uterus

Outcome Measures

Primary Outcomes (1)

• Incidence of hysterectomy at time of myomectomy.

  Jan 2020- Dec 2024

Secondary Outcomes (6)

• Characteristics of the Myomas who required hysterectomy

  Jan 2020- Dec 2024

• Intraoperative complications

  Jan 2020- Dec 2024

• Postoperative complications

  Jan 2020- Dec 2024

• Duration of hospital stay

  Jan 2020- Dec 2024

• Reoperation

  Jan 2020- Dec 2024

Study Arms (1)

Patient who were planned for abdomoinal myomectomy

A retrospective study on women who were candidates for abdominal myomectomy in the previous 4 years

Eligibility Criteria

• Gender Eligibility Details: Women who were planned for abdominal myomectomy
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Women who were planned to undergo abdominal myomectomy in the past 4 years

You may qualify if:

• Women planned for abdominal myomectomy in the previous 4 years.
• Availability of complete medical records for pre-, intra- and post-operative data.

You may not qualify if:

• Missing or lacking information in the patients records like preoperative assessment of the fibroid uterus.
• Absence of operative notes and relevant data in the medical files.

Sponsors & Collaborators

• Ain Shams University: lead

Study Sites (1)

Faculty of Medicine, Ain Shams University

Cairo, 11591, Egypt

Location

MeSH Terms

Conditions

Leiomyoma

Condition Hierarchy (Ancestors)

Neoplasms, Muscle Tissue; Neoplasms, Connective and Soft Tissue; Neoplasms by Histologic Type; Neoplasms

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Lecturer

Study Record Dates

• First Submitted: January 17, 2026
• First Posted: January 26, 2026
• Study Start: December 15, 2024
• Primary Completion: October 15, 2025
• Study Completion: October 15, 2025
• Last Updated: January 30, 2026

Record last verified: 2026-01

Locations

EG (1)